399 related articles for article (PubMed ID: 7258262)
1. Hirsutism: implications, etiology, and management.
Hatch R; Rosenfield RL; Kim MH; Tredway D
Am J Obstet Gynecol; 1981 Aug; 140(7):815-30. PubMed ID: 7258262
[TBL] [Abstract][Full Text] [Related]
2. Hirsutism and virilism in women.
Kirschner MA
Spec Top Endocrinol Metab; 1984; 6():55-93. PubMed ID: 6084314
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic evaluation of hirsutism in women.
Farber M; Millan VG; Turksoy RN; Mitchell GW
Clin Obstet Gynecol; 1977 Mar; 20(1):1-9. PubMed ID: 837574
[TBL] [Abstract][Full Text] [Related]
4. Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and the adrenal in the pathogenesis of hirsutism.
Rittmaster RS; Thompson DL
J Clin Endocrinol Metab; 1990 Apr; 70(4):1096-102. PubMed ID: 2156885
[TBL] [Abstract][Full Text] [Related]
5. Determination of the source(s) of androgen overproduction in hirsutism associated with polycystic ovary syndrome by simultaneous adrenal and ovarian venous catheterization. Comparison with the dexamethasone suppression test.
Wajchenberg BL; Achando SS; Okada H; Czeresnia CE; Peixoto S; Lima SS; Goldman J
J Clin Endocrinol Metab; 1986 Nov; 63(5):1204-10. PubMed ID: 3760120
[TBL] [Abstract][Full Text] [Related]
6. Adrenal abnormalities in idiopathic hirsutism.
Moore A; Magee F; Cunningham S; Culliton M; McKenna TJ
Clin Endocrinol (Oxf); 1983 Apr; 18(4):391-9. PubMed ID: 6307551
[TBL] [Abstract][Full Text] [Related]
7. Modified dexamethasone and gonadotropin-releasing hormone agonist (Dx-GnRHa) test in the evaluation of androgen source(s) in hirsute women.
Bidzińska B; Tworowska U; Demissie M; Milewicz A
Przegl Lek; 2000; 57(7-8):393-6. PubMed ID: 11109312
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic hirsutism--an ovarian abnormality.
Kirschner MA; Zucker IR; Jespersen D
N Engl J Med; 1976 Mar; 294(12):637-40. PubMed ID: 1246257
[TBL] [Abstract][Full Text] [Related]
9. The clinical evaluation of hirsutism.
Somani N; Harrison S; Bergfeld WF
Dermatol Ther; 2008; 21(5):376-91. PubMed ID: 18844715
[TBL] [Abstract][Full Text] [Related]
10. Ovulation after glucocorticoid suppression of adrenal androgens in the polycystic ovary syndrome is not predicted by the basal dehydroepiandrosterone sulfate level.
Azziz R; Black VY; Knochenhauer ES; Hines GA; Boots LR
J Clin Endocrinol Metab; 1999 Mar; 84(3):946-50. PubMed ID: 10084576
[TBL] [Abstract][Full Text] [Related]
11. Androgens in women: Androgen-mediated skin disease and patient evaluation.
Bienenfeld A; Azarchi S; Lo Sicco K; Marchbein S; Shapiro J; Nagler AR
J Am Acad Dermatol; 2019 Jun; 80(6):1497-1506. PubMed ID: 30312644
[TBL] [Abstract][Full Text] [Related]
12. [Plasma androgens and testosterone binding globulin levels in hirsute women. Effects of dexamethasone and oestrogen-progestagen administration (author's transl)].
Pugeat M; Forest MG; Corniau J; De Peretti E; Benhamed M; Tourniaire J
Nouv Presse Med; 1982 Jan; 11(2):105-9. PubMed ID: 7199136
[TBL] [Abstract][Full Text] [Related]
13. Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism.
Tiitinen A; Simberg N; Stenman UH; Ylikorkala O
J Clin Endocrinol Metab; 1994 Aug; 79(2):447-51. PubMed ID: 8045961
[TBL] [Abstract][Full Text] [Related]
14. Treatment with dexamethasone of androgen excess in adolescent patients.
Emans SJ; Grace E; Woods ER; Mansfield J; Crigler JF
J Pediatr; 1988 May; 112(5):821-6. PubMed ID: 3361397
[TBL] [Abstract][Full Text] [Related]
15. [Correlations between clinical signs and hormonal parameters in young women with hirsutism].
Kristesashvili J; Chanukvadze D
Georgian Med News; 2011 Nov; 11(200):30-5. PubMed ID: 22201077
[TBL] [Abstract][Full Text] [Related]
16. Acne, hirsutism, and alopecia in adolescent girls. Clinical expressions of androgen excess.
Rosenfield RL; Lucky AW
Endocrinol Metab Clin North Am; 1993 Sep; 22(3):507-32. PubMed ID: 8243445
[TBL] [Abstract][Full Text] [Related]
17. Comparison between buserelin and dexamethasone testing in the assessment of hirsutism.
Re T; Barbetta L; Dall'Asta C; Faglia G; Ambrosi B
J Endocrinol Invest; 2002 Jan; 25(1):84-90. PubMed ID: 11883870
[TBL] [Abstract][Full Text] [Related]
18. Routine screening for Cushing's syndrome is not required in patients presenting with hirsutism.
Karaca Z; Acmaz B; Acmaz G; Tanriverdi F; Unluhizarci K; Aribas S; Sahin Y; Kelestimur F
Eur J Endocrinol; 2013 Mar; 168(3):379-84. PubMed ID: 23221034
[TBL] [Abstract][Full Text] [Related]
19. Influence of body mass index on measured and calculated androgen parameters in adult women with Hirsutism and PCOS.
Cupisti S; Dittrich R; Binder H; Kajaia N; Hoffmann I; Maltaris T; Beckmann MW; Mueller A
Exp Clin Endocrinol Diabetes; 2007 Jun; 115(6):380-6. PubMed ID: 17701884
[TBL] [Abstract][Full Text] [Related]
20. Clinical presentation and etiologic factors of hirsutism in premenopausal Iranian women.
Ansarin H; Aziz-Jalali MH; Rasi A; Soltani-Arabshahi R
Arch Iran Med; 2007 Jan; 10(1):7-13. PubMed ID: 17198446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
